InvestorPlace - Stock Market News, Stock Advice & Trading Tips
LVTX stock results show that LAVA Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
The post LVTX Stock Earnings: LAVA Therapeutics Beats EPS, Misses Revenue for Q1 2024 appeared first on InvestorPlace.
More From InvestorPlace